acut
respiratori
tract
infect
rti
known
worsen
asthma
particularli
children
studi
adult
assess
incid
rti
patient
hospit
acut
asthma
aim
document
incid
rti
adult
hospit
acut
asthma
method
prospect
studi
patient
acut
asthma
admit
depart
respiratori
medicin
western
hospit
footscray
period
control
group
studi
elect
surgic
inpati
patient
investig
serolog
test
chlamydia
mycoplasma
legionella
influenza
b
nasopharyng
aspir
npa
sampl
cultur
influenza
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
rhinoviru
herp
simplex
viru
sputum
avail
assess
microscopi
cultur
blood
cultur
taken
patient
febril
patient
chest
radiograph
control
subject
complet
serolog
test
np
result
seventynin
patient
male
femal
control
subject
male
femal
studi
two
patient
enrol
twice
mean
age
patient
year
rang
year
mean
age
control
subject
year
rang
year
patient
group
evid
recent
rti
viral
five
control
subject
evid
recent
rti
p
twentyfour
patient
posit
serolog
andor
np
cultur
five
patient
posit
serolog
test
result
andor
np
cultur
two
agent
two
patient
test
posit
sputum
radiograph
temperatur
criteria
three
patient
test
posit
basi
radiograph
evid
consolid
blood
neutrophilia
temperatur
influenza
rhinoviru
common
infecti
agent
agent
identifi
rsv
one
influenza
b
two
adenoviru
one
mycoplasma
one
influenza
rhinoviru
infect
occur
predominantli
late
earli
winter
respect
summer
hospit
relat
rti
conclus
thirtyseven
percent
adult
patient
acut
asthma
admit
depart
respiratori
medicin
period
evid
recent
rti
chest
role
respiratori
tract
infect
rti
evolut
acut
exacerb
asthma
continu
defin
mani
studi
children
shown
associ
rti
deterior
asthma
symptom
acut
asthma
exacerb
children
thought
relat
viral
rtij
situat
adult
less
clear
older
studi
show
rti
associ
asthma
exacerb
recent
studi
assess
rate
rti
acut
exacerb
adult
asthma
beasley
et
al
longitudin
outpati
studi
shown
incid
viral
rti
acut
sever
adult
asthma
exacerb
mild
asthma
exacerb
nicholson
et
al
also
longitudin
studi
adult
asthmat
home
shown
object
evid
rti
asthma
exacerb
prospect
studi
perform
period
assess
incid
rti
adult
acut
asthma
exacerb
requir
admiss
gener
hospit
metropolitan
melbourn
australia
prospect
studi
perform
commun
hospit
western
suburb
melbourn
australia
studi
approv
hospit
research
ethic
committe
patient
control
subject
recruit
august
juli
patient
match
basi
sex
age
control
subject
control
subject
recruit
simultan
patient
avoid
potenti
season
bia
asthma
patient
receiv
standard
therapi
iv
andor
oral
steroid
bronchodil
antibiot
requir
asthma
patient
recruit
via
emerg
depart
hospit
admit
respiratori
medic
unit
control
subject
recruit
elect
surgic
admiss
subject
gave
inform
consent
enter
studi
diagnosi
asthma
defin
histori
variabl
peak
expiratori
flow
rate
pefr
andor
fev
least
either
therapi
spontan
patient
control
subject
underw
detail
histori
includ
question
subject
evid
recent
rti
asthma
symptom
nasopharyng
aspir
npa
perform
subject
aspir
cultur
influenza
b
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
rhinovirus
coronavirus
herp
simplex
viru
victorian
infecti
diseas
refer
laboratori
vidrl
fairfield
victoria
australia
npa
perform
patient
upright
posit
fin
e
steril
nasal
cannula
attach
steril
suction
trap
pass
posterior
nasopharynx
via
nostril
suction
appli
cannula
tip
withdrawn
nasopharynx
insert
steril
salin
solut
ml
salin
solut
suction
trap
contain
npa
specimen
examin
within
h
sampl
subject
underw
initi
first
bleed
serolog
test
possibl
furth
er
convalesc
serum
sampl
taken
week
follow
admiss
studi
serum
sampl
examin
evid
acut
infect
legionella
speci
mycoplasma
pneumonia
chlamydia
infect
via
chlamydia
common
antigen
influenza
b
patient
also
chest
radiograph
full
blood
examin
sputum
microscopi
cultur
assess
look
eosinophil
neutrophil
pathogen
febril
time
hospit
admiss
asthma
patient
blood
cultur
taken
npa
cultur
virus
vidrl
cultur
identif
virus
perform
techniqu
previous
publish
sputum
microscopi
cultur
procedur
sputum
obtain
asthma
patient
patient
product
cough
microscopi
perform
sputum
gram
stain
low
power
xloo
oil
immers
len
qualit
report
leukocyt
squamou
cell
organ
made
smear
sputum
cultur
hors
blood
agar
hba
optichon
disc
bectondickinson
spark
md
chocol
blood
agar
cba
bacitracin
macconkey
agar
hba
cba
plate
incub
h
fungal
element
seen
sputum
also
cultur
subouraud
dextros
agar
antibiot
day
cultur
report
posit
pathogen
streptococcu
pneumonia
haenwphilu
influenza
cultur
pseudomona
aeruginosa
streptococci
group
b
c
g
staphylococcu
aureu
klebsiella
pneunwnia
consid
pathogen
cultur
organ
predomin
smear
leukocyt
present
smear
clinic
histori
blood
cultur
perform
incub
fluoresc
read
system
bactec
per
manufactur
hand
book
bectondickinson
spark
md
blood
inject
bottl
cultur
bactec
plu
aerob
f
bactec
anaerob
f
first
bleed
possibl
second
bleed
serolog
test
perform
vidrl
mycoplasma
igm
titer
measur
revers
enzymelink
immunosorb
assay
techniqu
diatech
diagnost
ltd
israel
total
antibodi
pneunwnia
measur
passiv
particl
agglutin
test
fujeribio
inc
japan
chlamydia
psittaci
antibodi
assess
complement
fixat
test
cft
use
virion
cft
antigen
chlamydia
control
antigen
virion
ltd
rueschlikon
switzerland
influenza
b
antibodi
assess
cft
whitak
bioproduct
md
legionella
antibodi
measur
immunofluoresc
use
antihuman
iga
igg
igm
h
l
vith
igg
fraction
fluorescein
isothiocyanateconjug
silenu
hawthorn
australia
legionella
standard
strain
obtain
american
type
cultur
collect
rockvil
md
diagnosi
recent
rti
made
subject
one
follow
fourfold
increas
antibodi
titer
pair
sera
high
igm
antibodi
titer
first
bleed
serolog
test
avail
growth
virus
npa
cultur
posit
sputum
cultur
respiratori
pathogen
associ
sputum
blood
neutrophilia
temperatur
admiss
neg
serolog
test
re
ult
np
sputum
cultur
chest
radiograph
evid
lobar
consolid
collaps
atelectasi
temperatur
admiss
evid
allerg
bronchopulmonmi
aspergillosi
sputum
sampl
full
blood
examin
total
ige
specif
ige
aspergillu
differ
patient
control
group
analyz
either
mannwhitney
rank
sum
test
ztest
compar
proport
vith
yate
correct
appli
calcul
result
consid
significantli
differ
seventynin
patient
acut
exacerb
asthma
hospit
respiratori
medic
unit
control
subject
recruit
studi
period
adult
admit
hospit
acut
exacerb
respiratori
medic
unit
medic
unit
hospit
chose
recruit
patient
admit
respiratori
medic
unit
patient
admit
asthma
medic
unit
also
evid
major
medic
ill
may
confound
result
patient
admit
respiratori
medic
unit
recruit
trial
miss
predominantli
logist
reason
rather
refus
enter
studi
major
reason
asthma
patient
nonrecruit
trial
admiss
hospit
weekend
period
physician
conduct
trial
leav
nonrecruit
trial
relat
season
demograph
characterist
patient
control
group
given
tabl
l
monthli
patient
admiss
number
hospit
trial
shown
figur
l
peak
patient
admiss
hospit
occur
late
winter
spring
earli
summer
less
patient
admiss
occur
late
summer
autumn
twentynin
patient
evid
recent
rti
compar
five
control
group
p
twentythre
patient
evid
recent
viral
infect
predominantli
influenza
rhinovirus
serolog
andor
npa
cultur
criteria
tabl
thirteen
patient
evid
recent
influenza
infect
two
evid
recent
influenza
b
infect
nine
evid
recent
rhinoviru
infect
five
patient
evid
one
viral
infect
tabl
peak
influenza
late
winter
earli
spring
period
wherea
rhinoviru
infect
occur
predominantli
earli
winter
three
patient
either
discuss
found
evid
recent
rti
adult
patient
admit
hospit
respiratori
medic
unit
period
acut
exacerb
asthma
contrast
earli
previou
studi
adult
asthmat
found
rti
present
time
acut
exacerb
inde
tarlo
et
al
find
associ
rti
asthma
exacerb
adult
long
postul
mani
asthma
exacerb
precipit
rti
children
shown
asthma
exacerb
associ
respiratori
tract
infect
case
though
rti
present
asthmat
children
studi
without
asthma
exacerb
studi
children
hospit
asthma
evid
recent
viral
infect
horn
et
alp
howev
found
children
acut
asthma
exacerb
evid
rhinoviru
infect
sputum
higher
rate
rti
children
asthma
exacerb
compar
adult
thought
partli
due
delay
present
adult
manag
rapid
clear
virus
often
occur
adult
lead
increas
difficulti
isol
virus
adult
older
studi
difficulti
isol
rhinoviru
coronaviru
infect
although
tri
cultur
coronavirus
npa
find
infect
organ
perhap
fastidi
natur
studi
identifi
one
patient
evid
recent
mycoplasma
infect
mycoplasma
infect
occur
epidem
suggest
littl
mycoplasma
occur
commun
patient
recruit
period
found
patient
rhinoviru
cultur
npa
combin
npa
cultur
viral
serolog
also
found
incid
influenza
b
infect
patient
result
viral
rti
associ
acut
asthma
exacerb
lower
nicholson
et
al
prospect
studi
adult
outpati
asthmat
found
incid
nonbacteri
pathogen
term
sever
asthma
episod
mean
decreas
pefr
umin
also
found
laboratoryconfirm
rti
associ
mean
decreas
pefr
umin
day
author
also
abl
identifi
coronaviru
infect
noncommerci
enzymelink
immunosorb
assay
techniqu
rhinovirus
seminest
revers
transcriptas
polymeras
chain
reaction
prospect
studi
beasley
e
al
assess
recent
rti
acut
asthma
exacerb
adult
outpati
set
though
overal
found
evid
rti
acut
asthma
exacerb
state
incid
viral
rti
sever
asthma
exacerb
author
howev
specifi
criteria
sever
asthma
found
adult
asthma
patient
evid
rti
also
exacerb
asthma
vari
sever
knowledg
studi
second
prospect
work
assess
associ
recent
rti
adult
acut
asthma
requir
hospit
abramson
et
al
casecontrol
studi
patient
older
year
admit
hospit
acut
asthma
found
evid
recent
viral
rti
asthmat
group
time
chanc
viral
rti
control
group
studi
larger
number
patient
specif
assess
patient
older
year
reduc
likelihood
find
may
secondari
high
background
incid
rti
within
gener
commun
time
studi
attempt
recruit
control
subject
ageand
sexmatch
patient
control
subject
recruit
simultan
patient
ageand
sexmatch
difficulti
recruit
entir
period
howev
clear
rate
rti
within
control
group
lower
asthmat
patient
control
subject
howev
select
group
admit
hospit
elect
surgeri
find
incid
recent
rti
may
underestim
gener
commun
although
incid
figur
rti
agent
commun
time
frame
studi
indic
pathogen
commun
data
collect
vidrl
n
lehmann
person
commun
data
taken
serolog
np
sputum
sampl
sent
refer
laboratori
patient
ill
rti
overal
winter
rsv
predomin
pathogen
spring
influenza
virus
common
earli
spring
viral
infect
uncommon
summer
adenovirus
parainfluenza
virus
predomin
autumn
rhinovirus
adenovirus
parainfluenza
virus
common
figur
seem
influenza
mycoplasma
outbreak
commun
month
studi
n
lehmann
person
commun
inde
rsv
adenovirus
parainfluenza
note
frequent
vidrl
data
infrequ
associ
asthma
exacerb
studi
reason
unclear
perhap
latter
infect
occur
predominantli
children
andor
less
like
caus
increas
bronchial
reactiv
adult
compar
influenza
virus
data
regard
pollen
count
year
melbourn
show
total
grass
pollen
per
annum
occur
novemb
decemb
tree
pollen
mainli
elm
cypress
predomin
late
winter
earli
spring
taken
togeth
data
suggest
late
winter
earli
spring
popul
expos
number
rti
pathogen
tree
pollen
could
potenti
caus
asthma
wherea
summer
though
rti
pathogen
less
evid
grass
pollen
abund
autumn
earli
winter
rti
pathogen
common
commun
hospit
admiss
rate
adult
patient
acut
asthma
show
patient
admit
five
month
august
decemb
inclus
wherea
four
month
januari
april
inclus
year
total
number
patient
admit
fig
therefor
tempt
suggest
group
patient
worst
time
acut
exacerb
asthma
late
winter
spring
earli
summer
relat
high
level
commun
rti
pathogen
high
environment
pollen
count
believ
incid
rti
occur
adult
patient
acut
exacerb
asthma
requir
hospit
could
underestim
number
patient
fail
return
convalesc
serum
sampl
result
viral
infect
may
miss
addit
unabl
specif
cultur
chlamydia
pneurrwnia
strain
tw
ar
infect
organ
previous
implic
asthma
exacerb
studi
adult
acut
exacerb
asthma
use
polymeras
chain
reaction
techniqu
viral
identif
may
identifi
higher
incid
rti
adult
subject
possibl
may
overestim
frequenc
rti
patient
use
criteria
chest
radiograph
consolid
associ
fever
blood
neutrophilia
diagnost
infect
howev
criteria
use
routin
clinic
practic
diagnos
pneumonia
studi
etiolog
hospit
communityacquir
pneumonia
infect
organ
identifi
least
case
similarli
isol
organ
sputum
like
pathogen
set
associ
sputum
neutrophilia
fever
without
chest
radiograph
abnorm
altern
may
underestim
number
patient
bacteri
rti
antibiot
therapi
prior
admiss
hospit
reliabl
data
confirm
deni
possibl
though
patient
studi
deni
recent
antibiot
therapi
interest
clinic
observ
frequenc
fever
patient
acut
exacerb
asthma
requir
hospit
one
could
postul
fever
could
secondari
inflammatori
process
asthma
alon
howev
perhap
surprisingli
popul
find
fever
common
asthmat
evid
recent
rti
compar
without
patient
evid
recent
rti
afebril
admiss
hospit
may
exhibit
ongo
increas
bronchial
reactiv
secondari
rti
occur
within
week
prior
hospit
evid
anim
human
experiment
support
concept
viral
rti
caus
ongo
bronchial
inflamm
bronchial
addit
previous
state
adult
asthma
patient
may
present
hospit
late
diseas
sever
even
evid
recent
rti
patient
may
afebril
time
hospit
summari
believ
studi
demonstr
strong
associ
recent
rti
sever
acut
exacerb
asthma
adult
requir
hospit
asthma
incid
influenza
infect
group
support
view
adult
signific
longterm
asthma
influenza
vaccin
earli
basi
would
advis
rti
found
patient
group
viral
suggest
antibiot
therapi
withheld
acut
sever
exacerb
asthma
unless
high
clinic
microbiolog
suspicion
acut
bacteri
infect
